Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com
StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research note published on Monday. The firm issued a sell rating on the biotechnology company’s stock. A number of other brokerages have also commented on APTO. Alliance Global Partners upgraded shares of Aptose Biosciences to a “strong-buy” rating in a […]
StockNews.com started coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research note published on Monday. The firm issued a sell rating on the biotechnology company’s stock. A number of other brokerages have also commented on APTO. Alliance Global Partners upgraded shares of Aptose Biosciences to a “strong-buy” rating in a […]
